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Chapter 1
Zusammenfassung
Die Innervierung der Skelettmuskulatur durch Motorneurone fu¨hrt zur Bildung von neu-
romuskulren Synapsen (NMS). Agrin, ein von Nerven sezerniertes Protein, zusammen
mit Lrp4, bekannt als Agrin Rezeptor, fu¨hrt zur Aktivierung der muskelspezifischen
Rezeptortyrosinkinase, MuSK. Diese Aktivierung von MuSK resultiert in der Phospho-
rylierung von spezifischen Tyrosinen im MuSK-eigenen intrazellula¨ren Bereich. Dieser
Prozess ist essentiell fu¨r alle bekannten Aspekte post- und pra¨synaptischer Differen-
zierung, inklusive der postsynaptischen Anreichung von Acetylcholinrezeptoren (AChR).
MuSK knock-out Ma¨use haben keine neuromuskula¨ren Synapsen und sterben gleich nach
der Geburt aufgrund respiratorischen Versagens. AChRs und andere synaptische Pro-
teine befinden sich gleichma¨ssig auf der Muskelfaser verteilt. Zusammengefasst sind
Agrin und MuSK Schlu¨sselfiguren fu¨r die Entwicklung der neuromuskula¨ren Synapse.
Die Mechanismen, die die Expression, die Stabilita¨t und die Lokalisierung von MuSK an
der Muskeloberfla¨che, und damit den Signalweg von MuSK beeinflussen, sind noch nicht
bekannt.
Studien u¨ber andere Rezeptortyrosinkinase (RTKs) haben gezeigt, dass die Endozytose
von Zelloberfla¨chenrezeptoren die Signalwege beeinflussen ko¨nnen. Die Aktivierung von
RTKs fu¨hrt zur Aktivierung von intrazellula¨ren Signalwegen, die wichtig fu¨r verschiedene
Zellprozesse sind, wie zum Beispiel die Proliferation, Differenzierung, die Migration und
das U¨berleben der Zellen. Liganden-induzierte Rezeptorendozytose ist fu¨r die Weiter-
gabe und Spezifisierung von Signalen notwendig. Somit, besteht ein enger Zusammen-
hang zwischen Endozytose und Signalu¨bertragung. Im Muskel sind endosomale Kom-
partimente reichlich unter der NMS exprimiert und daher wird die Endozytose als sehr
wichtig bei der Kontrolle der postsynaptischen Rezeptordichte angesehen.
Diese Diplomarbeit hatte zum Ziel MuSK Endozytose und deren Einfluss auf Agrin-
induziertes AChR Clustering zu untersuchen. Mittels der Blockierung von Dynamin
Funktion, ko¨nnte ich zeigen, dass die MuSK Endozytose in HeLa Zellen stark beeintra¨chtigt
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wurde. Dies impliziert, dass Dynamin2 eine wichtige Rolle in der MuSK Endozytose
spielt. Dynasore, ein chemischer Inhibitor von Dynamin, reduzierte im groen Ausma das
Agrin-induzierte AChR Clustering in Muskelzellen. Dies bekra¨ftigt, dass die Dynamin-
abha¨ngige MuSK Endozytose eine wichtige Rolle bei der Aktivierung der MuSK-spezifischen
Signalwege spielt. Dynasore erwies sich als wichtiges Werkzeug bei der Blockierung von
Dynamin-abha¨ngiger Endocytose und half daher bei der Untersuchung von MuSK En-
dozytose und ihren Einfluss auf die Agrin-MuSK Signalwirkung. In weiteren Experi-
menten wurde eine Muskelzelllinie erzeugt, die getaggtes MuSK exprimiert. Die Gener-
ierung dieser Muskelzelllinie ero¨ffnet Mo¨glichkeiten bei der Untersuchung von MuSK-
Endozytose in Muskelzellen. So kann man MuSK in lebenden Zellen markieren und
dessen Wanderung in Zellen beobachten. Dadurch konnte ich mo¨gliche Co-Lokalisationen
zwischen MuSK und spezifischen endozytischen Kompartimenten visualisieren.
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Chapter 2
Summary
The innervation of skeletal muscle by motor neurons leads to the formation of neuro-
muscular synapses (NMSs). Agrin, a nerve-derived protein, together with Lrp4 known
as the agrin receptor, leads to the activation of muscle-specific receptor tyrosine kinase
MuSK. Phosphorylation of several tyrosine residues in the MuSK intracellular domain is
essential for all known aspects of postsynaptic and presynaptic differentiation, including
the postsynaptic clustering of acetylcholine receptors (AChRs).
MuSK knock-out mice fail to form NMSs, die shortly after birth due to respiratory failure
and their AChRs and other synaptic proteins are uniformly expressed along the muscle
fibers.
Taken together, agrin and MuSK are the key players at developing NMSs that initiate pre-
and post-synaptic differentiation. Mechanisms that regulate surface MuSK expression,
stability, localization and consequently influence MuSK signaling pathways are as yet un-
resolved. Studies on other receptor tyrosine kinases (RTKs) have shown that endocytosis
and trafficking of cell surface receptors can modulate signaling pathways. Activation of
RTKs leads to the induction and specification of intracellular signaling pathways which
are important for cellular behaviour like proliferation, differentiation, motility and sur-
vival.
These findings demonstrate that receptor trafficking and signaling are closely linked. In
the muscle, endosomal compartments are highly concentrated beneath the NMSs and
endocytosis is considered to be of particular importance in the control of postsynaptic
receptor density.
This study aimed to better characterize MuSK endocytosis and its influence on agrin in-
duced AChR clustering. By blocking dynamin function I could show that MuSK endocy-
tosis is severely affected in HeLa cells, indicating a role for dynamin in MuSK endocytosis.
The dynamin inhibitor, dynasore significantly reduced agrin-induced AChR clustering in
muscle cells, which supports the idea that dynamin-dependent MuSK endocytosis might
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be important for agrin-MuSK signaling at the NMS. Dynasore, proved to be a powerful
tool in blocking dynamin dependent endocytosis and studying MuSK endocytosis and its
influence on agrin-MuSK signaling.
Another tool in studying MuSK trafficking in muscle cells was the production of a muscle
cell line that expresses a tagged MuSK. This allows the labelling of MuSK in living cells
and the visualisation of trafficking processes. This cell line will allow a better character-
isation of MuSK endocytosis in muscle cells.
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Chapter 3
Introduction
3.1 The neuromuscular synapse
The neuromuscular junction (NMJ) also called neuromuscular synapse (NMS) represents
the contact side between the axon terminal of a motor neuron and a muscle fiber. This
excitable region of the muscle fiber plasma membrane is named motor end plate. A
mature and functional NMS is an anatomical and physiological key element in the pro-
cess of muscle contraction. The nervous impulse initiated in the center nervous system
is transmitted along motor axons to the muscle fiber. The increase of Ca2+ ions in
the axon terminal cytosol of the motor neuron leads to the release of neurotransmitter
acetylcholine (ACh) in the synaptic cleft. ACh will diffuse and reversibly bind to nicotinic
acetylcholine receptors (nAChRs) from the postsynaptic membrane. nAChRs are ligand-
gated ion channels and the binding of ligand (ACh) leads to a opening of the channel
and the diffusion of Na+ and K+ across the receptor pore. This causes depolarization of
voltage-gated sodium channels, which allows initiation of the action potential (AP). AP
is propagated along the membrane and T-tubules to the sarcoplasmic reticulum where
Ca2+ will be released into the cytosol and binds to troponin-C. This causes a confor-
mational change that moves tropomyosin out of the way so that the cross bridges can
attach to actin and produce muscle contraction. A schematic representation of the motor
neuron, NMS and muscle fiber is shown in figure 3.1.
3.2 Synaptogenesis of the neuromuscular synapse
Neuromuscular synapses are functional even before birth, but still many transformations
take place to generate a mature postsynaptic apparatus from the nascent AChR cluster.
A fully mature NMS is characterized by its highly folded postsynaptic membrane as well
as the highly differentiated nerve terminal as shown in figure 3.1.
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Figure 3.1: Cartoon of the motor neuron, NMS and muscle fiber. Axon terminals from
a motor neuron project toward muscle; synaptic knob containing vesicles with neuro-
transmitters, postjunctional folds, T-tubules and sorcoplasmic reticulum are despicted
(picture by Charles Mallery: fig.cox.miami.edu/ cmallery/150/neuro/muscle.htm.)
Figure 3.2: The neuromuscular junction. a — The neuromuscular junction of an adult
mouse. b — Three synapses on cultured mouse hippocampal neurons shown at the same
scale.In green is the motor neuron terminals and in yellow is the postsynaptin membrane
(image published by Sanes and Lichtman, 2001).
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AChRs are specifically concentrated at the NMS beneath the motor nerve terminal. Its
density in this region is > 10.000/µ m2 compared with the extrasynaptic membrane
where it is < 10/µ m2 [Fambrough, 1979]. The AChRs are localized exclusively at the
crests of postsynaptic folds [Burden, 2002] and specific changes such as the clustering of
nuclei to synaptic sites, expression of AChR mRNA in synaptic areas and suppression
of AChR gene transcription in non-synaptic nuclei contribute to the establishment of a
fully mature synapse [Cohen et al., 1997].
AChR subunit composition is changed as the embryonic form of AChRs containing γ-
subunits is replaced by AChRs containing the homologous -subunits [Numberger et al., 1991].
This results in shorter channel opening times, but the channel conductance and its Ca2+
permeability increases.
During embryonic development (embryonic day 11 in mice) myoblasts begin to fuse,
forming multinucleated skeletal muscle fibers. After formation of these premature mus-
cle fibers, growth cones of motor neurons arrive, start branching and begin to establish
nerve-muscle contact (E12-E13) [Burden, 2002]. Until E14.5 few aneuraly AChR clus-
ters are detectable, located in the center region of the muscle [Lin et al., 2001]. This
phenomenon can also be observed on myotubes cultured without neurons were ”spon-
taneous” AChR clusters, often called ”hot spots” can be observed [Vogel et al., 1972,
Fischbach & Cohen, 1973, Bloch, 1979]. This supports the idea that AChR clusters might
form aneurally and then are recognized by the ingrowing axon. In vivo, the presence of
nerve will lead to a redistribution of AChR clusters in a distinct region termed the end-
plate zone [Luo et al., 2003], a process finished at E16-E18. In a mature NMS, the initially
flat postsynaptic membrane develops its characteristic gutters and folds and motor axons
are myelinated and synapse elimination assures that only one axon is present at each
NMS (reviewed in Sanes and Lichtman 2001).
3.3 NMS serves as a model system
The NMS is a very good model system in studying structural, functional and molecular
aspects of a synapse. There are different reasons for that. First, as shown in figure 3.2,
the NMS has a large size and is geometrically relative simple. Secondly, NMSs are readily
accessible and NMSs are easy to see, partly because they are well separated from each
other [Sanes & Lichtman, 2001]. Studies on the NMS can be performed in vivo, as well
in vitro, due to the existence of muscle cell lines.
Additionally, the electric organ of Torpedo californica serves as a resource to isolate synap-
tic components in relatively large amounts [Cartaud et al., 2000] and α-bungarotoxin
(BTX), a 74-amino-acid polypeptide, the main component present in the deadly venom
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of Bungaris multicinctus, binds specifically and quasi-irreversibly to muscle and electric
organ AChRs [Lee et al., 1967]. This provided an important tool in research, for ex-
ample 125I-BTX was initially used to identify AChRs, agarose-BTX was used to purify
AChRs, and rhodamine-BTX was used to localize AChRs and to track their movements.
Understanding the molecular properties of the NMS should help researchers to develop
drugs for severe diseases such as Myasthenia gravis, Lambert Eaton syndrome, congenital
myasthenic syndromes and the large group of muscle dystrophies.
3.4 Agrin, MuSK and Lrp4 - the major players in
synapse formation
MuSK and Lrp4 are two receptors involved in postsynaptic differentiation at developing
and adult NMSs. The importance of MuSK and Lrp4 became obvious through mouse
molecular genetics approaches. MuSK deficient mice lack any postsynaptic specializa-
tions at the nerve-muscle contact and die perinatally [DeChiara, 1996]. Lrp4-mutant
mice die at birth with defects in both presynaptic and postsynaptic differentiation, in-
cluding aberrant motor axon growth and branching, a lack of acetylcholine receptor and
postsynaptic protein clustering, and a failure to express postsynaptic genes selectively
by myofiber synaptic nuclei [Weatherbee et al., 2006]. Agrin, which is released by motor
terminals and deposited in the synaptic basal lamina, is the third key player during NMS
developing. Agrin-deficient mice do not form functional postsynaptic structures and also
die immediately after birth due to respiratory failure [Gautam et al., 1996].
3.4.1 Agrin
McMahan and colleagues noticed that the extracellular matrix of the NMS was suffi-
cient to instruct synapses to re-form after losing nerve stimulation [Sanes, 1978]. This
indicated that a trophic factor stably incorporated into the synaptic basal lamina was
sufficient to induce pre- and postsynaptic differentiation. This factor was named agrin
from the Greek ”‘agrein”’ meaning ”‘to assembly”, named after its ability to aggregate
AChRs. The protein agrin was purified using the synapse-rich electric organ of the pa-
cific electric ray Torpedo californica [Nitkin, 1987]. The gene encodes a protein of more
than 2000 amino acids with a predicted molecular mass of 225 kDa, which can be in-
creased to 600 kDa due to extensive N- and O-linked glycosylation of the amino-terminus.
At least three of the O-linked carbohydrate attachment sites function as docking sites
for heparan sulphate glycosaminoglycan (HS-GAG) side chains and assign agrin to the
family of heparin sulfate proteoglycans [Tsen et al., 1995]. Agrin contains multiple epi-
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Figure 3.3: Structural domains of Agrin. LG, laminin globular domain; NCAM, neuronal
cell adhesion molecule; S/T, serine/threonine-rich region; SEA, sea urchin sperm protein,
enterokinase, agrin domain; (scheme published by Bezakova and Ruegg, 2003; modified).
dermal growth factor (EGF)-like signaling domains, two different laminin like domains,
and multiple follistatin-like repeats (figure3.3). The four EGF-like domains and three
laminin-like G domains are contained in the carboxy-terminal region, which is sufficient
to induce AChR clusters in cultured myotubes; sequences in the amino-terminal region
are thought to be responsible for the association of agrin with the extracellular matrix
[McMahan, 1990, Tsen et al., 1995].
Amino-acid inserts at the Z site are crucial for agrin-induced AChR aggregation [Burgess et al., 1999].
On cultured myotubes, only the isoforms that contain an insert (called agrin-Z+) induce
AChR aggregation and this activity is absent when the insert at the Z site is missing
(called agrin-Z-) [Ruegg & Bixby, 1998]. The main source for the active agrin isoforms,
those that can induce aggregation, is represented by neurons, including motor neurons.
The signal sequence (SS) and amino (N)-terminal agrin domain (NtA) are present in an
agrin isoform that is localized at the NMS. These two regions are responsible for the secre-
tion of agrin (SS) and the binding to the basal lamina (NtA) [Bezakova & Ruegg, 2003].
3.4.2 MuSK
The Muscle-Specific Kinase (MuSK) is crucial for agrin triggered signaling at the NMS.
Cultured myotubes devoid of MuSK do not aggregate AChR in response to agrin, and
the ability of myotubes to aggregate AChR recovers after MuSK expression in restored
[Herbst & Burden, 2000].
Agrin can activate MuSK in cultured myotubes, but not in myoblasts or other cells ex-
pressing MuSK [Glass et al., 1996], which implies that differentiated muscle cells contain
another entity that functions as an ’agrin receptor’. This was identified as being Lrp4
(Low-density lipoprotein-receptor-related protein 4), that is also crucial for the formation
of the NMS [Weatherbee et al., 2006]. It was shown that agrin can stimulate phosphory-
lation of MuSK in nonmuscle cells expressing Lrp4 and MuSK. The workgroup of Steven
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Figure 3.4: Schematic drawing of the MuSK protein. MuSK contains four immunglogulin-
like (Ig) domains and one cysteine-rich (C6) domain in its extracellular portion which
is separated from the intracellular part by a single transmembrane domain (TM). The
cytosolic domain can be divided into a juxtamembrane (JM) domain and a kinase do-
main (TK). Tyrosines in these two domains become phosphorylated in response to agrin.
Tyrosine 553, which lies within an NPXY motif in the JM domain has been shown to be
essential for AChR clustering.
Burden determined that Lrp4 is sufficient to reconstitute agrin-stimulated MuSK phos-
phorylation in BaF3 cells that expressed MuSK and Lrp4 [Kim et al., 2008], and the
workgroup of Lin Mei showed that Lrp4 expression enables MuSK activation by agrin in
HEK293 cells [Zhang et al., 2008].
As shown in figure 3.4, MuSK is a transmembrane receptor, with a cytoplasmatic, extra-
cellular and transmembrane domain. The cytoplasmatic domain, contains the tyrosine
kinase domain and shows similarities with neurotrophin receptors. The extracellular do-
main contains four immunoglobulin-like domains and a cysteine-rich domain. The MuSK
intracellular domain contains a juxtamembrane domain, a kinase domain and an eight
amino acid carboxy-terminal tail [Valenzuela et al., 1995].
The cytoplasmic domain of MuSK contains 17 tyrosine residues within the kinase do-
main and one tyrosine residue in the juxtamembrane region [Valenzuela et al., 1995].
Only 6 of these tyrosine residues (shown in figure 3.4) are accessible for phosphorylation
[Watty et al., 2000]. It was shown that the juxtamembrane tyrosine residue Y553 is es-
sential for downstream signaling, since myotubes expressing MuSK Y553F fail to cluster
AChRs in response to agrin. MuSK Y553 is further required to stimulate AChR β-subunit
tyrosine phosphorylation, which precedes, but is not required for AChR clustering. This
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suggests that MuSK activates or recruits a kinase that has a role in catalyzing tyrosine
phosphorylation of AChRs and stimulating AChR clustering [Herbst & Burden, 2000].
More than that, Y553 is located within an NPXY motif, which can function as an in-
ternalization signal in other membrane receptors [Chen et al., 1990] and, when phospho-
rylated serves as a binding motif for proteins containing phosphotyrosine-binding (PTB)
domains [Blaikie et al., 1994, Kavanaugh & Williams, 1994]. This finding supports the
idea, that phosphorylated tyrosines act as docking sites for molecules that pass on the
signal elicited by agrin [Herbst & Burden, 2000].
3.4.3 Agrin signal transduction events at the neuromuscular
synapse
Agrin initiates signal transduction events starting with MuSK activation [Jennings & Burden, 1993,
Glass et al., 1996]. This requires its agrin co-receptor Lrp4 [Kim et al., 2008, Zhang et al., 2008].
After its activation, MuSK signals via the proteins called Casein kinase 2 (CK2) [Cheusova et al., 2006],
Dok-7 [Okada et al., 2006] and rapsyn, to induce ”clustering” of acetylcholine receptors
(AChR). Both CK2 and Dok-7 are required for MuSK induced formation of the neuromus-
cular junction, since mice lacking Dok-7 failed to form AChR clusters or neuromuscular
synapses, and since downregulation of CK2 also impedes recruitment of AChR to the
primary MuSK scaffold.
MuSK phosphorylation and subsequent activation of several intracellular enzymes are nec-
essary for agrin-induced AChR aggregation. Among this enzymes, are tyrosine kinases
such as Abl and Src-family members [Finn et al., 2003, Sadasivam et al., 2005], geranyl-
geranyltransferase I, a metalloenzyme involved in protein prenylation [Luo et al., 2003],
the serine kinase casein kinase 2 [Cheusova et al., 2006], small GTPases of the Rho family
[Luo et al., 2002], and p21-activated kinase (PAK) / Dishevelled (Dvl) [Luo et al., 2003].
In vitro studies indicate a necessary role of these enzymes for agrin-induced AChR ag-
gregation
Taken together, at the NMS, receptors such as MuSK, ErbBs, integrins might activate dis-
tinct signaling pathways that tailor cytoskeletal architecture, allow the integration of di-
verse signals and activate the transcription of synapse-specific genes [Sadasivam et al., 2005].
A schematic drawing of agrin-induced signaling events at the NMS is shown in figure 3.5.
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Figure 3.5: Signaling activated by agrin-B/z+ at the NMS. At the NMS, agrin activates
MuSK and other receptors and this leads to the aggregation of acetylcholine receptors
(AChRs). Integrins engaged by agrin directly or indirectly (through binding to laminin)
might participate in cytoskeletal re-organization through focal adhesion kinase (FAK) and
Src. Activated MuSK, ErbB receptors and integrins might in turn activate transcription
factors such as c-jun and GABP to initiate synaptic transcription. The newly synthesized
proteins, such as AChR, rapsyn (R) and utrophin might further stabilize the postsynapse
by connecting it to the cytoskeleton. Formation and maintenance of a mature postsynapse
involves ’crosstalk’ between distinct pathways. Cortactin might function as a checkpoint
for several pathways involved in the cytoskeleton rearrangement. Dystroglycan stabilizes
the mature synapse by connecting the basal lamina to the cortical F-actin cytoskeleton.
Integrins might also contribute to the stability of the NMS by regulating the turnover
of focal contacts through Src and PAK. PAK is recruited to integrin through a paxillin
scaffold. Dotted arrows with question marks indicate hypothetical interactions. The
requirement of GABP and c-jun for MuSK, ErbB and rapsyn transcription has not been
investigated. GABP, guanidine and adenosine-binding protein; PIK, PAK-interacting
exchange factor; PKL, paxillin kinase linker (published by Bezakova and Ruegg, 2003).
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Figure 3.6: Pathways of entry into cells. Large particles can be taken up by phagocytosis,
whereas fluid uptake occurs by macropinocytosis. Numerous cargoes can be endocytosed
by mechanisms that are clathrin and dynamin dependent, caveolin and dynamin depen-
dent or clathrin and caveolin independent. Most internalized cargoes are delivered to the
early endosome via vesicular (clathrin- or caveolin-coated vesicles) or tubular interme-
diates (known as clathrin- and dynamin-independent carriers (CLICs)) that are derived
from the plasma membrane. Some pathways may first traffic to intermediate compart-
ments, such as the caveosome or glycosyl phosphatidylinositol-anchored protein enriched
early endosomal compartments (GEEC), en route to the early endosome (published by
Mayor and Pagano, 2007).
3.5 Endocytosis and signaling
3.5.1 Short classification of endocytosis
There are numerous ways that endocytic cargo molecules may be internalized from the
surface of eukaryotic cells. A short classification is shown in figure 3.6. Any endocytic
pathway that mediates the transport of a specific cargo will first require mechanisms
for selection at the cell surface. Next, the plasma membrane must be induced to bud
and pinch off. Finally, mechanisms are required for tethering these vesicles to the next
stop on their itinerary and for inducing their subsequent fusion to this target membrane
[Mayor & Pagano, 2007].
In this study I focused my attention on dynamin dependent endocytosis to better char-
acterize MuSK internalization and its influence on agrin induced signaling at the NMS.
Shown in figure 3.7, are different types of endocytosis that are dynamin dependent.
Dynamin was originally noted for its role in severing clathrin-coated vesicles from the
plasma membrane and was subsequently found to be involved in a clathrin-independent
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Figure 3.7: Dynamin involvement in different endocytic mechanisms. A cargo protein can
be endocytosed by either clathrin-dependent or clathrin-independent (CI) mechanisms.
The CI pathways can be further categorized first by their dependence on the large GT-
Pase dynamin, and then by other mechanistic components of the internalization pathway
(published by Mayor and Pagano, 2007).
(CI) pathway that is mediated by caveolae. Because vesicle scission at the plasma mem-
brane is required for subsequent internalization, it was initially assumed that dynamin
might have a role in all forms of endocytosis. However, it was later discovered that some
CI pathways are dynamin-independent, at least when they are assessed by monitoring
cargo internalization in the context of exogenous expression of mutant dynamin isoforms
[Damke, 1995] or from analysis of organisms that are homozygous for mutant dynamin
[Guha et al., 2003].
3.5.2 Dynamin and dynasore influence on endocytosis
Dynamin, a 100-kDa GTPase, is an essential component of vesicle formation in receptor-
mediated endocytosis, synaptic vesicle recycling, caveolae internalization, and possibly
vesicle trafficking in and out of the Golgi. In addition to the GTPase domain, dynamin
also contains a pleckstrin homology domain (PH) implicated in membrane binding, a
GTPase effector domain (GED) shown to be essential for self-assembly and stimulated
GTPase activity, and a C-terminal proline-rich domain (PRD), which contains several
SH3-binding sites (figure 3.8). Dynamin interaction partners bind to the PRD and may
either stimulate GTPase activity or target dynamin to the plasma membrane. Purified
dynamin readily self-assembles into rings or spirals. This striking structural property
supports the hypothesis that dynamin wraps around the necks of budding vesicles where
it plays a key role in membrane fission [Hinshaw, 2000].
Although only one dynamin isoform has been identified in Drosophila and Caenorhab-
ditis elegans [Chen et al., 1991], in mammals three closely related isoforms have been
identified, for review see [Urrutia et al., 1997]. Dynamin 1, found specifically in neuronal
tissue [Scaife, 1990], has 8 splice variants [Bonifacino et al., 1998] and has been mapped
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Figure 3.8: Diagram of dynamin dimer domain structure where the small arrows indicate
intra-molecular interactions between domains. GED is GTPase effector domain, (picture
from http://www.endocytosis.org/Dynamin/Middle-GED.html).
to human chromosome 9q34 [Newman-Smith et al., 1997]. Dynamin 2 is ubiquitously
expressed [Cook et al., 1994] and has 4 splice variants [Bonifacino et al., 1998], whereas
dynamin 3, expressed predominantly in testes [Nakata, 1993], but also found in lung and
neurons [Cook et al., 1996], has 13 splice variants [Bonifacino et al., 1998]. It was schown
that different dynamin isoforms play overlapping roles in different types of endocytosis.
For example, it was shown that dynamin 1 and dynamin 2 simultaneously participate
in the clathrin-independent and -dependent membrane retrieval in pancreatic beta cells
[Lu et al., 2008].
Dynamin 2 dominant negative mutant (dyn2-K44A) more potently inhibited receptor-
mediated endocytosis than dyn1-K44A in HeLa cells and at the basolateral surface of
polarized MDCK cells. In contrast, dyn1(K44A) more potently inhibited endocytosis at
the apical surface of MDCK cells [Altschuler et al., 1998].
Another important discovery in studying dynamin dependent endocytosis was ”‘dyna-
sore”’. Macia and colleagues [Macia et al., 2006] have discovered ”‘dynasore”’ in their
search through approximately 16,000 small molecules to identify a chemical inhibitor for
dynamin. Dynasore functions as an inhibitor of dynamin 1 and dynamin 2 GTPase ac-
tivity and blocks endocytic functions previously shown to require dynamin. Previously
methods such as siRNA and expression of dominant-negative dynamin have been used
to test dynamin-mediated processes. These methods are slow acting and could produce
secondary effects [Thompson & McNiven, a]. Dynasore acts fast and reversible, is cell
permeable and offers a direct and precise tool in blocking dynamin dependent endocyto-
sis.
3.5.3 Endocytosis and signaling of receptor tyrosine kinase
Endocytosis of receptor tyrosine kinases (RTKs) has been shown to be necessary for
intracellular signaling in response to various growth factors. The internalization of
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activated receptors leads to either attenuation of signaling via degradation of the lig-
and/receptor complex or reduction of signaling from endosomes [Ceresa & Schmid, 2000,
Wang et al., 2004]. The induction of the appropiate biological outcome requires signaling
of the correct magnitude, kinetics and specificity [Marmor & Yarden, 2004, Marshall, 1995].
Thus, signaling through RTKs must be subject to tight regulation. The epidermal growth
factor receptor (EGFR) has served as a paradigm for the elucidation of RTK-induced sig-
naling pathways. It was shown that ligand-induced receptor endocytosis is required for
signal transduction by the EGF receptor [Vieira et al., 1996, Brugge et al., 2001]. But
most importantly, it was shown that neuregulin-mediated endocytosis of ErbB receptor
tyrosine kinase is important for subsequent Erk activation which is required for AChR
expression [Yang et al., 2005]. In addition, it was shown that the internalization re-
quires the kinase activity of ErbB and involves a clathrin-dependent endocytic pathway.
These findings demonstrate that receptor trafficking and signaling are closely linked. In
the muscle, endosomal compartments are highly concentrated beneath the NMSs and
endocytosis is considered to be of particular importance in the control of postsynaptic
receptor density [Salpeter et al., 1993, Xu & Salpeter, 1997]. Furthermore, increasing ev-
idence implicate trafficking of synaptic proteins as crucial events during NMS formation
and maintenance. How localization and interacting proteins impact protein function and
influence signaling is an important theme, as is the potential for modulating signaling
through therapeutic targeting of activated receptors and components of the endocytic
machinery [Mukherjee et al., 2006].
Until now evidence has been provided, that inhibition of MuSK endocytosis attenuates
agrin-induced AChR clustering [Zhu et al., 2008]. The researchers could show that ex-
pression of a dominant-negative mutant of dynamin in muscle cells, reduces MuSK inter-
nalization and agrin-MuSK signaling. As a result, AChR clustering is also reduced. In
addition it was shown that MuSK undergoes ligand-mediated endocytosis, just like other
receptor tyrosine kinases such as EGFR and ErbB4 [Zhu et al., 2008].
3.5.4 Tagging receptors and following their internalization
An useful tool in following receptors internalization is to specifically label them with
fluorophores. McCann and collegues [McCann et al., 2005] developed a method where
they generated fusion proteins that incorporate short sequences recognized by strepta-
vidin (SA). SA is an ideal marker of transmembrane molecules because SA exhibits little
nonspecific binding, does not cross the cell membrane, accesses more sterically restricted
spaces than antibodies, does not interfere with protein localization or function due to its
small size and is more reliable than antibodies that are very large and thus can inter-
fere with endocytosis processes. The best available SA-binding sequence, called SBP-Tag
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[Keefe et al., 2001] is a 38-mer that recognizes the biotin binding site of SA. Thus, the
receptor of interest is tagged with SBP-Tag, pulse-labeled with different streptavidin
conjugates and its internalization visualized with a fluorescent microscope.
3.6 Aim of my project
Studies on RTKs have shown that endocytosis and trafficking of cell surface receptors can
modulate signaling pathways. The aim of this study is to characterize MuSK endocytosis
for a better understanding of its function in MuSK signaling. According to this theme,
my work had two main research aims. The first one was to ellucidate the role of dynamin
in MuSK endocytosis. Different questions had to be answered for this purpose, questions
like: is MuSK endocytosis dynamin dependent? What dynamin isoform is responsible for
MuSK endocytosis? Does perturbation of MuSK endocytosis using a dynamin dominant-
negative mutant or dynasore (a dynamin inhibitor) have an influence on agrin-induced
AChRs clustering in muscle cells? Another aim of my research was to generate a muscle
cell line expressing SBP-tagged MuSK, that can specifically be stained with different flu-
orophores and its internalization be followed. This allowed me to visualise colocalisations
of MuSK with different compartments of the endocytic pathway (early endosomes). The
results of this study are described in the next chapter.
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Chapter 4
Results
4.1 Influence of dynamin on MuSK endocytosis and
signaling
The effect of dynamin on MuSK endocytosis was studied in transfected HeLa cells where
MuSK-SBP was specifically labeled with fluorescently labeled streptavidin and its endo-
cytosis visualised with a fluorescence microscope. As shown in figure 4.1, the SBP-Tag
(SBP= streptavidin binding protein), is recognized by the biotin binding site of Strep-
tAvidin (SA). Different fluorophore conjugates of SA can be used for staining the cells
[McCann et al., 2005]. This allows us to specifically stain MuSK-SBP receptors and fol-
low their trafficking in transfected HeLa cells.
In order to see the influence of dynamin on MuSK-SBP endocytosis, HeLa cells were
cotransfected with a dominant-negative mutant of dynamin (dyn-K44A) or with dy-
namin wild-type (dyn-WT) and MuSK-SBP. Surface MuSK-SBP receptors were specif-
Figure 4.1: MuSK receptor expressing the SBP-Tag. SA-StreptAvidin. SBP-
StreptAvidin Binding Protein.
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Figure 4.2: Scheme representing experimental approach to check the effect of dynamin on
MuSK-SBP endocytosis in HeLa cells. HeLa cells are first cotansfected with MuSK-SBP
and dyn-K44A or dyn-WT. Cells are stained at 4◦C with SA-Cy3 (Streptavidin-Cy3),
incubated for x minutes in DMEM medium at 37◦C and then stained again at 4◦C with
SA-Cy5 (Streptavidin-Cy5).
ically stained at 4◦C with Streptavidin-Cy3 (SA-Cy3) or with Streptavidin-Alexa 594
(SA-Alexa 594), both represented in figures in red color. Afterwards, HeLa cells were
incubated at 37◦C when endocytosis occurs, for different time intervals. In some ex-
periments, surface MuSK-SBP was subsequently stained at 4◦C with Streptavidin-Cy5
(SA-Cy5) represented in figures in blue (figure 4.2). Cells were fixed in 4% PFA, mounted
in Vectashield medium and visualised with a fluorescence microscope.
4.1.1 Dynamin 1 and its influence on MuSK endocytosis in
HeLa cells
As a control experiment, a time course of MuSK-SBP endocytosis in HeLa cells was per-
formed (figure 4.3). Cells were transfected only with MuSK-SBP and stained at 4◦C with
SA-Cy3 (red). Cells were incubated at 37◦C for different time intervals, when endocytosis
occurs and surface MuSK-SBP was stained at 4◦C with SA-Alexa 488 (green). At time
point 0 cells were stained only at 4◦C with both fluorophores. A strong colocalisation of
surface MuSK-SBP receptors can be seen, represented by the yellow dots. For the other
time intervals we can see an accumulation of MuSK-SBP inside the cells (red staining),
representing endocytosis of the MuSK protein.
In order to study the effect of dynamin 1 on MuSK-SBP endocytosis, HeLa cells were
cotransfected with dyn1-K44A-GFP and MuSK-SBP. Cells were stained at 4◦C with SA-
Alexa 594 (red). Cells were incubated at 37◦C when endocytosis occurs, for different time
intervals. Subsequently cells were fixed and examined with a fluorescence microscope as
described in Materials and methods. As shown in figure 4.4, the dominant-negative
mutant of dynamin 1 did not inhibit MuSK-SBP endocytosis in HeLa cells. After 30
minutes incubation at 37◦C, MuSK-SBP clusters can be seen and after 2 hours MuSK-
SBP is internalised. As a primary conclusion of this experiment, dynmain 1 is not involved
in MuSK endocytosis in transfected HeLa cells because expression of dyn1-K44A does
not inhibit MuSK-SBP endocytosis.
28
Figure 4.3: Time course of MuSK-SBP endocytosis in transfected HeLa cells. In the
middle panel MuSK-SBP stained with SA-Cy3 (red) was incubated for different time
intervals: 0, 30, 60, 120 and 240 minutes. In the left panel surface MuSK-SBP was stained
with SA-Alexa 488 (green), after endocytosis took place. The right panel represents a
merge between SA-Cy3 and SA-Alexa 488.
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Figure 4.4: The effect of dynamin 1 on MuSK-SBP endocytosis in HeLa cells. HeLa cells
were transfected with dyn1-K44A-GFP and MuSK-SBP. In the top panel MuSK-SBP
is stained with SA-Alexa 594 (red) and incubated for different time intervals: 0, 15, 30
and 120 minutes at 37◦C. In the middle panel HeLa cells expressing dyn1-K44A-GFP
are shown. The bottom panel represents a merge between the first two panels. MuSK
internalization proceeds with increasing time intervals.
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4.1.2 Dynamin 2 and its influence on MuSK endocytosis in
HeLa cells
HeLa cells were cotransfected with a dynamin 2 dominant-negative mutant (dyn2-K44A-
GFP) or with dynamin 2 wildtype (dyn2-WT) and MuSK-SBP. Cells were stained at
4◦C with SA-Cy3 (red). Cells were incubated for 15 minutes at 37◦C when endocytosis
occurs. Surface MuSK-SBP was subsequently stained at 4◦C with SA-Cy5 (blue). Cells
were fixed and examined with a fluorescence microscope as described in Materials and
methods. As shown in figure 4.5, after 15 minutes incubation, cells transfected only
with MuSK-SBP, have intracellular clusters of MuSK-SBP. On the other hand, in the
cells transfected with dyn2-K44A, MuSK-SBP internalization was greatly delayed, and a
significant colocalisation is visible between MuSK incubated at 37◦C and surface MuSK
(magenta color). Cells transfected with dyn2-WT, had an increase in MuSK internaliza-
tion compared with the control cells. MuSK-SBP clusters are detectable in the middle of
the cell. As a conclusion, dynamin 2 seems to play a role during MuSK endocytosis.
Subsequently, I performed a time course for MuSK endocytosis in HeLa cells express-
ing dyn2-K44A. Cells were first transfected with dyn2-K44A and MuSK-SBP and then
surface MuSK-SBP was stained at 4◦C with SA-Cy3. Cells were incubated at 37◦C for
different time intervals and afterwards surface MuSK-SBP was stained at 4◦C with SA-
Cy5. Cells were fixed and visualised with a fluorescence microscope. MuSK-SBP stained
with SA-Cy3 (red) and incubated for 15, 30 and 60 minutes, colocalises with surface
MuSK-SBP stained with SA-Cy5 (blue), during this time points (figure 4.6). Internal
MuSK clusters are barely visible indicating that dynamin 2 affects MuSK endocytosis in
HeLa cells by regulating surface MuSK internalization.
4.1.3 Influence of MuSK kinase activity on dynamin 2 mediated
endocytosis in HeLa cells
Ligand-induced stimulation of RTKs often results in an increased endocytosis of the active
receptor. Since MuSK can not be stimulated with agrin in non-muscle cells, expression of
a constitutive-active MuSK protein represents an alternative to study the effect of kinase
activity on MuSK endocytosis. Over-expression of a constitutively-active MuSK mutant
(MuSK LS745/746MT) in COS cells confirmed that the kinase-domain is active without
agrin stimulation (Susan Luiskandl, unpublished data).
In this experiment I determined whether endocytosis of constitutively-active MuSK in
HeLa cells is also reduced upon expression of dyn 2-K44A. For this purpose a MuSK-
SBP-KA(constitutively-active) construct was produced. HeLa cells were cotransfected
with dyn2-K44A and MuSK-SBP-KA. As a control, cells were transfected only with
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Figure 4.5: Influence of dyn2-K44A and dyn 2-WT on MuSK-SBP endocytosis in trans-
fected HeLa cells. The left panel represents a control where HeLa cells were transfected
only with MuSK-SBP. The middle vertical panel represents HeLa cells transfected with
dyn2-K44A/MuSK-SBP and the right vertical panel represents HeLa cells transfected
with dyn2-WT/MuSK-SBP. The top panel shows HeLa cells transfected with dyn2-
K44A-GFP and dyn2-WT-GFP, the second panel represents MuSK-SBP stained with
SA-Cy3 (red) and incubated for 15 minutes at 37◦C. The third panel panel represents
surface MuSK stained with SA-Cy5 (blue) and the bottom panel is a merge between all
panels. The colocalisation between MuSK-SBP stained with SA-Cy3 (red) and surface
MuSK-SBP stained with SA-Cy5 (blue) is represented in magenta color.
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Figure 4.6: Influence of dynamin 2 on MuSK-SBP endocytosis in HeLa cells within differ-
ent periods of time. HeLa cells transfected with dyn2-K44A and MuSK-SBP were stained
at 4◦C with SA-Cy3 and incubated for 15, 30 and 60 minutes at 37◦C. Subsequently sur-
face MuSK-SBP was stained at 4◦C with SA-Cy5. The top panel represents HeLa cells
transfected with dyn2-K44A-GFP (green),the second horizontal panel represents MuSK-
SBP stained with SA-Cy3 (red)and incubated for 15, 30 and 60 minutes at 37◦C. The
third horizontal panel represents surface MuSK-SBP stained with SA-Cy5 (blue). The
bottom horizontal panel is a merge between the first 3 lanes. Magenta color represents the
colocalisation between MuSK-SBP stained with SA-Cy3 (red) and incubated for different
time intervals and surface MuSK-SBP stained with SA-Cy5 (blue).
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Figure 4.7: Influence of MuSK kinase activity on dynamin 2 mediated MuSK endocytosis.
HeLa cells were cotransfected with dyn2-K44A and MuSK-SBP-KA (kinase active) or
only with MuSK-SBP-KA in control experiment. Surface MuSK was stained at 4◦C with
SA-Cy3, cells were incubated at 37◦C for 45 minutes, and surface MuSK was stained with
SA-Cy5. The left panel shows HeLa cells, expressing dyn2-K44A-GFP. The second panel
represents MuSK-SBP-KA stained with SA-Cy3 (red), third panel represents surface
MuSK-SBP-KA stained with SA-Cy5 (artificial colored in green in the image), fourth
panel represents a merge between the previously two panels. The colocalisation between
SA-Cy3 (red) and SA-Cy5 (green) is represented in yellow color. The last lane represents
the control, in red is MuSK-SBP-KA stained with SA-Cy3,incubated for 45 minutes, and
in green is surface MuSK-SBP-KA stained with SA-Cy5 (artificially colored in green).
SA-Cy5 is shown in green since the overlap of red and green, (yellow) is visually better
perceived compared with magenta, the overlap of red and blue.
MuSK-SBP-KA. Cells were stained at 4◦C with SA-Cy3 (red), incubated for 45 minutes
at 37◦C, and then surface MuSK-SBP-KA was stained at 4◦C with SA-Cy5. Figure 4.7
shows that MuSK-SBP-KA was internalized when transfected alone, but when cotrans-
feced with dyn2-K44A, its endocytosis was inhibited. Numerous yellow dots representing
colocalisations between internalised MuSK-SBP-KA and surface MuSK-SBP-KA are vis-
ible.
4.1.4 Influence of dynasore on MuSK endocytosis in HeLa cells
Dynasore, a cell-permeable small molecule was discovered by Macia et al. as an inhibitor
of dynamin endocytic functions [Macia et al., 2006]. Dynasore inhibits all dynamin iso-
forms involved in endocytosis. It acts fast and provides an useful tool in studying en-
docytic and dynamin-dependent mechanisms. In this experiment HeLa cells were trans-
fected with MuSK-SBP. I first performed a starvation, where cells were kept in DMEM
medium for 30 minutes. Afterwards a preincubation with dynasore was performed (the
inhibitor was added to cells medium for 30 minutes). This time period was shown in
different publications as sufficient for dynasore to act and block dynamin dependent
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endocytosis. As a control, DMSO was added to the medium (because dynasore was dis-
solved in DMSO). Cells were washed in cold PBS and MuSK-SBP was stained at 4◦C
with SA-Cy3. Cells were incubated in medium with dynasore or DMSO at 37◦C for 45
minutes to let endocytosis occur. After 45 minutes, cells were washed in cold PBS and
surface MuSK-SBP was stained at 4◦C with SA-Alexa488. Cells were fixed in 4% PFA
and mounted in Vectashield medium. Cells were visualised with a fluorescence micro-
scope. In cells treated with dynasore, MuSK-SBP endocytosis was inhibited (figure 4.8).
A strong colocalisation between MuSK-SBP stained with SA-Cy3 and surface MuSK-SBP
stained with SA-Alexa488 is observed demonstrating an effect on MuSK endocytosis. On
the other hand, in control experiment, where cells were not preincubated with dynasore,
big red clusters of MuSK-SBP stained with SA-Cy3 can be observed inside the cell and
little colocalisation with surface MuSK-SBP stained with SA-Alexa488 is visible. Thus,
blocking dynamins, we interfere with MuSK-SBP internalization in transfected HeLa
cells.
4.1.5 Influence of dynasore on agrin induced AChR clustering
in muscle cells
To test whether inhibition of dynamin-dependent endocytosis has an effect on MuSK
signaling, agrin-induced AChR clustering was studied in the presence of dynasore.
C2C12 myoblasts were switched to differentiation medium to induce myotubes forma-
tion. Myotubes were preincubated for 30 minutes with dynasore, DMSO, or left in DM
(differentiation medium). Subsequently, agrin was added to the medium to induce AChR
cluster formation for 8 hours. Cells were fixed in 4% PFA and AChRs were stained with
α-BGT-Alexa 594 and sampels were visualised with a fluorescence microscope. Number
and length of AChRs clusters were quantified from at least 10 fields visualized with a
63X obiective. As shown in figure 4.9 dynasore interferes with AChR clustering. Agrin-
induced AChR clusters in myotubes treated with dynasore are smaller and their number
is incresed.
4.1.6 Influence of dynasore on AChR phosphorylation after agrin
stimulation
Stimulation of muscle cells with agrin leads to AChR clustering. In addition, the agrin/MuSK
signaling pathway involves tyrosine phosphorylation of the AChRβ subunit. Since the
previous experiment revealed an effect of dynasore on AChR clustering, I tested whether
dynasore affects AChR β tyrosine phosphorylation. C2C12 myotubes were first incubated
in medium with dynasore, DMSO or left in DMEM for 30 minutes. Agrin was added
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Figure 4.8: Influence of dynasore on MuSK-SBP endocytosis in HeLa cells. MuSK-SBP
transfected cells were preincubated with dynasore or with DMSO (control). Surface
MuSK-SBP was stained at 4◦C with SA-Cy3 (red) and cells were subsequently incubated
at 37◦C for 45 minutes. Afterwards, surface MuSK-SBP was stained at 4◦C with SA-
Alexa488 (green). First vertical panel from right, represents MuSK-SBP stained with SA-
Cy3 (red), middle vertical panel represents surface MuSK-SBP stained with SA-Alexa488
(green) and the left vertical panel represents a merge between SA-Cy3 and SA-Alexa488.
Yellow dots represent the colocalisation between SA-Cy3 and SA-Alexa488.
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Figure 4.9: Influence of dynasore on agrin induced AChR clustering in muscle cells.
Myotubes were preincubated with dynasore, DMSO, or left in DM for 30 minutes. Cells
were incubated for 8 hours with agrin to induce AChR cluster formation. AChRs were
stained with α-BGT-Alexa 594. AChR clusters from 10 fields visualised with a 63X
obiective were counted and measured. Quantification, using the Metamorph Imaging
Software (Molecular Devices) was done from 5 different samples (n=5), and results were
collected from 2 independent experiments. The standard deviation (SD) is shown.
to the medium for an additional 30 minutes. Cells were lysed in RIPA buffer supplied
with inhibitors, biotin-α-BGT was added to label AChRs and AChRs were pulled down
using streptavidin agarose beads. Sampels were resolved by SDS-PAGE and immunoblot-
ted with anti-phosphotyrosine antibody (α-PTy) and anti-AChR antibody (α-AChRβ).
Agrin induced AChR phosphorylation was significantly reduced in myotubes pretreated
with dynasore (figure 4.10).
A similar experiment was performed in C2C12 muscle cells, where cells were incubated
with agrin for 30, 60 and 120 minutes. Figure 4.11 shows that AChRβ phosphorylation
was reduced for all time intervals in cells incubated with dynasore compared with control
experiments.
4.2 Generation of a muscle cell line expressing MuSK-
SBP
In order to follow MuSK endocytosis in muscle cells, a MuSK
−/−
muscle cell line express-
ing SBP-tagged MuSK was generated (C3.16/MuSK-SBP). C3.16 cells are myoblasts
from embryonic muscle cells of MuSK
−/−
mice. Thus they express no endogenous MuSK
protein [Herbst & Burden, 2000]. A retroviral expression vector containing MuSK-SBP
was constructed and MuSK
−/−
myoblasts were infected. Puromycin resistant clones were
selected and tested for differentiation, MuSK expression, MuSK tyrosine phosphorylation
and AChR cluster formation.
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Figure 4.10: Influence of dynasore on agrin-induced AChRβ phosphorylation. C2C12
myotubes were incubated with dynasore, DMSO or DMEM for 30 minutes and than
stimulated with agrin for 30 minutes. Cells were lysed and AChRs were pulled down us-
ing biotin-α-BGT-streptavidin agarose beads. Samples were resolved by SDS-PAGE and
immunoblotted with antibodies against phosphotyrosine (PTy) and AChRβ. Quantifi-
cation of the results was performed with BioRad Quantity One Analysis Software. The
result from 5 different experiments (n=5) is shown. The phosphorylated proteins were
normalised to the total amount of proteins and the results from the experiment where
cells were incubated only in DMEM as 100%. The error bars represent the standard
deviation (n=5).
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Figure 4.11: Influence of dynasore on agrin-induced AChRβ phosphorylation. C2C12
myotubes were incubated with dynasore, DMSO or DMEM for 30 minutes and than
stimulated with agrin for 30, 60 and 120 minutes. Cells were lysed and AChRs were pulled
down using α-biotin-BGT-streptavidin agarose beads. Samples were resolved in SDS-
PAGE and immunoblotted with antibodies against phosphotyrosine (PTy) and AChRβ.
Quantification of the blot was performed with BioRad Quantity One Analysis Software.
The phosphorylated proteins were normalised to the total amount of proteins and the
results from the experiment where cells were incubated only in DMEM for 30 min were
set as 100%. In this figure are the results from one experiment.
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4.2.1 Generation of pBabe/MuSK-SBP vector
MuSK-SBP was released from the original vector [McCann et al., 2005] using EcoRI (fig-
ure 4.12). The eluted fragment was ligated into pBabe (figure 4.13) and transformed
into SURE bacteria. The bacteria were selected over night on ampicillin medium. 10
colonies were multiplied in a over night culture and the DNA plasmid was extracted
using a mini-prep kit.
Figure 4.12: Isolation of the MuSK-SBP fragment. Enzyme digestion products (1-2) were
run on agarose gel. Successful and distinctive bands of expected size ( 3400bp) can be
seen, representing the desired MuSK-SBP fragment. M marker,1-2: double probes of the
same enzyme digestion.
Two control digests were performed. The first one was to check the release of MuSK-
SBP insert with EcoRI enzyme (figure 4.14 A). The second digest was performed to check
the orientation of the insert with Bgl II and Spe I enzymes (figure 4.14 B). One sample
contained the plasmid with a correct inserted MuSK-SBP fragment. The accuracy of the
inserted MuSK-SBP fragment was checked by sequencing.
4.2.2 Selection of different cell lines
Pheonix cells, a retrovirus producer cell line, were transfected with pBabe-MuSK-SBP
plasmid. Pheonix cells express the envelope proteins of the retrovirus and help to pro-
duce a functional retrovirus. The virus containing medium was used to infect MuSK
−/−
myoblasts. Infected cells were cultivated on selection medium containing puromycin. In
order to select only single cell clones, cells were plated at low density. Every cell gave
rise to a clone. 12 clones were picked and transfered into a multi-well dish. Each clone
was tested for differentiation and MuSK expression. From the 12 cell lines only 6 devel-
oped myotubes when induced to differentiate. These lines were further used to determine
MuSK-SBP expression and agrin induced MuSK phosphorylation.
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Figure 4.13: Scheme of pBabe vector. Length: 5169 bp. ORI: origin. Ampicillin and
puromycin resistance.
Figure 4.14: Restriction analysis of vector DNA. A, Control digest with EcoRI enzyme to
check the presence of MuSK-SBP fragment. The numbers in red are the positives. The
numbers in black do not contain MuSK. B, Control digest with Bgl II and Spe I enzymes
to check if the MuSK-SBP fragment was inserted in the correct orientation. Digestion
products (1-5) were run on an agarose gel. Only the sample number 3 was positive. M:
Marker.
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Figure 4.15: Phosphorylation and expression of MuSK-SBP in MuSK
−/−
cells. C3.16
MuSK-SBP myotubes derived from cell clones (10, 7, 6, 5, 3, 2) were stimulated with
agrin (+) or kept in medium without agrin (-). MuSK-SBP was precipitated using strep-
tavidin agarose beads, sampels were separated by SDS-PAGE and analyzed by Western
immunoblot. In the first panel we can see MuSK-SBP expression, the blot was incubated
with anti-MuSK antibodies and in the second panel we can see MuSK phosphorylation,
the blot was incubated with antibodies against phosphotyrosine (PTy). C, control, lysates
from MuSK
−/−
myotubes were used for the pull down.
4.2.3 MuSK expression and agrin induced MuSK phosphoryla-
tion
Parallel experiments were performed, where myotubes were stimulated for 30 min with
agrin, or were kept in medium without agrin. The cells were subsequently lysed and
MuSK-SBP was pulled down using streptavidin agarose beads. The isolated MuSK-
SBP protein was analyzed by immunoblotting. Figure 4.15 shows, that not all cell lines
expressed MuSK. Cell line number 10,7 and 6 expressed MuSK-SBP at higher levels.
Most importantly MuSK-SBP is phosphorylated in response to agrin in cell line number
10 and 6. As a control for the pull down I used MuSK
−/−
myotubes that express no
endogenous MuSK protein.
4.3 Characterisation of cell lines
4.3.1 Agrin induced AChR clustering in C3.16/MuSK-SBP my-
otubes
C3.16/MuSK-SBP myotubes were stimulated for 8 hours with agrin 4.8 or with agrin 0.0
(inactive form) to induce AChR cluster formation. Cells were fixed in 4% PFA, stained
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Figure 4.16: C3.16/MuSK-SBP myotubes form AChR clusters in response to agrin.
AChRs were stained with α-BGT-Alexa-594 and clusters were visualized with a fluo-
rescence microscope. In the first panel left are shown myotubes stimulated with inactive
agrin (agrin 0.0). The other 3 panels represent myotubes with agrin-induced AChR clus-
ters.
with α-BGT-Alexa-594 and visualized using a fluorescence microscope. Figure 4.16 shows
C3.16/MuSK-SBP myotubes and agrin-induced AChR clusters. Agrin-induced AChR
clusters could not be observed in myotubes treated with agrin 0.0 in contrast to myotubes
treated with agrin 4.8 where AChR clusters are readily visible. I used cells derived
from clone number 10, due to the high MuSK-SBP expression and due to the fact that
myoblasts differentiate very well.
4.3.2 Time course of agrin-induced MuSK phosphorylation in
C3.16/MuSK-SBP myotubes
In order to find the optimal time for agrin to induce the highest MuSK-SBP phospho-
rylation, I performed the following experiment: C3.16/MuSK-SBP myotubes were stim-
ulated for different time intervals with agrin. Cells were lysed in modified RIPA buffer
and MuSK-SBP was pulled down using streptavidin agarose beads. Samples were run in
SDS-PAGE followed by Western blotting. Figure 4.17 shows that a 30 minutes stimula-
tion with agrin induces the strongest MuSK-SBP phosphorylation in C3.16/MuSK-SBP
myotubes. This is further supported by a quantification shown in figure 4.18.
4.3.3 Assembly of agrin induced AChR clusters
For a better understanding of the agrin-MuSK signaling kinetics, I performed an ex-
periment in order to define the optimal time for agrin stimulated AChR clustering.
43
Figure 4.17: Phosphorylation of MuSK in C3.16-MuSK-SBP myotubes stimulated with
agrin for different time intervals. Myotubes were stimulated for different time intervals
with agrin (5-120 minutes), cells were lysed in modified RIPA buffer and MuSK-SBP was
pulled down by streptavidin agarose beads. Samples were subjected to SDS PAGE and
Western blot analysis, using an anti-phosphotyrosine antibody and α-MuSK as primary
antibodies.
Figure 4.18: Quantification of MuSK phoshorylation after agrin stimulation for different
time periods. The immunoblot from figure 4.17 was quantified using BioRad Quantity
One Analysis Software.
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Figure 4.19: Assembly of agrin-induced AChR clusters. AChR clusters from at least 10
fields visualised with a 63X obiective were counted and measured, using the Metamorph
Imaging Software (Molecular Devices) and the quantification was finalised with Microsoft
Excel. The standard deviation (SD) is shown.
C3.16/MuSK-SBP myotubes were stimulated for different time intervals with agrin. Cells
were fixed and AChR were stained with α-BGT-Alexa-594. Samples were analysed with
a fluorescence microscope. The number and length of clusters were counted in more than
10 fields per plate representing one time point. The highest number of agrin induced
AChR clusters is obtained after 8 hours of agrin-stimulation and the longest agrin-induced
AChR clusters are obtained after a stimulation with agrin from 8 to 12 hours (figure 4.19).
4.4 Colocalisation of MuSK and AChR in agrin in-
duced clusters
C3.16/MuSK-SBP myotubes were stimulated with agrin for 8 hours to induce AChR
cluster formation. Afterwards cells were fixed and MuSK-SBP was stained with SA-Alexa
488 and AChRs with α-BGT-Alexa-594. Sampels were examined with a fluorescence
microscope. The colocalisation between MuSK-SBP and AChRs is schown in the figure
4.20.
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Figure 4.20: Colocalisation of MuSK-SBP and AChR clusters in agrin stimulated my-
otubes. AChR are stained with α-BGT-Alexa-594, MuSK is stained with SA-Alexa 488,
last panel: merge between the first 2 panels. Yellow color represents AChR and MuSK
colocalisation
4.5 Internalization of MuSK in C3.16/MuSK-SBP
myotubes
4.5.1 MuSK, AChRs and Cholera-toxin-stained lipid rafts at
the NMS
It was previously shown that agrin stimulates a dynamic translocation of the AChR
into lipid rafts-cholesterol and sphingolipid-rich microdomains in the plasma membrane
[Pato et al., 2008]. This follows MuSK partition into lipid rafts and requires its activa-
tion [Zhu et al., 2006]. Fluorophores conjugated to cholera-toxin B-subunit (CT-FITC),
which binds to the lipid raft constituent ganglioside GM1 can be used to visualise lipid
rafts. Using CT-FITC I tried to visualize MuSK-SBP and AChRs distribution in the
lipid raft platform in agrin stimulated muscle cells. For this purpose, C3.16 MuSK-SBP
myotubes were stimulated for 8 hours with agrin to induce AChR clustering. Cells were
stained at 10◦C with α-BGT-Alexa-594, CT-FITC and SA-Cy5. Cells were washed for 5
minutes in PBS to reduce background staining, and then fixed in 4 % PFA and mounted
with Vectashield Mounting Medium. Sampels were visualized with a fluorescence micro-
scope. Figure 4.21 shows a colocalisation between AChRs marked by α-BGT-594 and
MuSK-SBP marked by SA-Cy5 within lipid rafts marked by CT-FITC.
4.5.2 Colocalisation of MuSK-SBP with EEA1 early endosomes
at the NMS
MuSK-SBP receptor can be specifically stained with SA (StreptAvidin) conjugated with
different fluorophores and its internalization followed in C3.16/MuSK-SBP myotubes.
Different endosome markers are commercially available and this offers another important
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Figure 4.21: Colocalisation of lipid rafts, AChR clusters and MuSK-SBP in myotubes.
AChRs are stained with α-BGT-Alexa-594 (red), lipid rafts are stained with CT-FITC
and MuSK-SBP stained with SA-Cy5(blue). Yellow color represents AChR-α-BGT-
Alexa-594 and lipid rafts-CT-FITC colocalisation.
tool in characterising MuSK endocytosis in muscle cells. We can specifically stain different
endocytic compartments (Rab5, EEA1, etc.) and visualise the possible colocalisations
between internalised MuSK-SBP and the specifically labeled endosomes. C3.16/MuSK-
SBP myotubes were stained at 37◦C for one hour with SA-488. Cells were stimulated with
agrin for 10 minutes to accelerate MuSK internalization. Cells were fixed in 4 % PFA
and EEA1 early endosomes were stained as described in Materials and methods. Sampels
were mounted in Vectashield and visualised with a fluorescence microscope. Some possible
colocalisation between MuSK-SBP and EEA1 early endosomes can be observed in figure
4.22.
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Figure 4.22: Colocalisation of MuSK-SBP with EEA1 early endosomes. All four images
represent regions in C3.16/MuSK-SBP myotubes where MuSK-SBP is stained with SA-
488 (green) and EEA1 early endosomes with Cy3 (red). Possible colocalisations (yellow
dots) between internalised MuSK and EEA1 endosomes are indicated by arrows.
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Chapter 5
Discussion
5.1 Influence of dynamin on MuSK endocytosis and
signaling
5.1.1 Influence of dynamin 1 on MuSK endocytosis
Dynamin 1 is a neuron-specific guanosine triphosphatase thought to be critically required
for the fission reaction of synaptic vesicle endocytosis. However, dynamin 1 was found
to influence endocytosis processes not only in neuronal cells. For example, in polarized
epithelial MDCK cells, dynamin 1 and dynamin 2 share endocytic functions depending
on their localisation at the plasma membrane [Altschuler et al., 1998]. Clathrin-coated
vesicle process is mediated by dynamin-1, whereas the slower form of endocytosis is
mediated by dynamin-2. In my work I could show that MuSK endocytosis in HeLa cells
is not dynamin 1 dependent. My findings are consistent with the fact that Eps15 mutants
were unable to inhibit MuSK endocytosis when expressed in HeLa cells but inhibited the
internalisation of transferrin (Susan Luiskandl, unbublished data). Eps15 (Epidermal
growth factor receptor pathway substrate 15) is a protein present at clathrin-coated pits
and is involved in receptor-mediated endocytosis [Benmerah et al., 1998]. It was also
shown that MuSK does not colocalise with transferrin in HeLa cells. All these data
suggest that MuSK endocytosis in HeLa cells is not dependent on dynamin 1 function
and occurs independent of clathrin-coated pits.
5.1.2 Influence of dynamin 2 on MuSK endocytosis
Dynamin 2 is thought to control receptor-mediated endocytosis in virtually all somatic
cells, as it is ubiquitously distributed and this form of endocytosis is universal. The first
isoform of dynamin 2, dynamin 2a, is implicated in caveolar uptake from the plasma mem-
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brane since a dominant negative mutant interferes with this type of internalization. The
second isoform, dynamin 2b appears instead to be involved in the known ”‘kiss-and-run”’
interactions between caveosomes and early endosomes [Mukherjee et al., 2006]. ”‘Kiss-
and-run”’ is a mode of membrane fusion and retrieval without the full collapse of the
vesicle into the plasma membrane. Expression of dynamin 2a K44A, greatly inhibited
MuSK endocytosis in HeLa cells, suggesting a role of dynamin 2 in MuSK endocytosis.
Though, this finding does not elucidate whether MuSK endocytosis is caveolar, small
GTPases (Rho A), actin, Arf6 or flotillin-1 dependent since dynamin 2a is involved in all
of this types of endocytic mechanisms. To confirm the role of dyn 2, I used dynasore,
which is a dynamin inhibitor. It inhibits both dynamins involved in endocytosis. My
findings showed that dynasore also blocks MuSK endocytosis in HeLa cells. Even if dy-
nasore does not resolve the question which dynamin isoform is involved in an endocytic
mechanism, because it blocks all dynamin isoforms, it sustains the finding that dynamin
2 is important for MuSK endocytosis in HeLa cells.
Expressing a dominant negative dynamin mutant, in this case dynamin-2a K44A could
also have non-speciffic effects, such as an increase in endosomal pH [Huber et al., 2001],
whereas dynasore has been shown to cause no or little unspecific side-effects. It was previ-
ously shown that agrin induces rapid internalization of MuSK in muscle cells [Zhu et al., 2008].
Agrin induced activation of MuSK can be mimiced in HeLa cells using a constitutively
active MuSK mutant. My experiments showed that endocytosis of active MuSK in HeLa
cells was also blocked when cotransfected with dynamin-2a K44A indicating that active
and inactive MuSK are internalised by the same endocytic machinery. It has been pro-
posed that dynamin plays an important role in tyrosine kinase receptor-mediated signal
transduction. In support of this hypothesis, dynamin has recently been shown to co-
precipitate with a number of receptor tyrosine kinase, including the epidermal growth
factor receptor [Seedorf et al., 1994] and the insulin receptor/insulin receptor substrate
I complex [Ando et al., 1994] via joint interactions with Grb2. Dynamin is complexed
with Grb2 in the absence or presence of growth factors, but becomes associated with
the respective tyrosine-phosphorylated receptor only upon growth factor stimulation
[Seedorf et al., 1994]. In addition, Scaife et al. [Scaife et al., 1994] report that the asso-
ciation of dynamin with phospholipase C and the platelet-derived growth factor receptor
is further increased with growth factor stimulation [Urrutia et al., 1997].
5.1.3 The role of dynamin during AChR clustering
Other important findings of my diploma thesis showed that dynasore reduces agrin in-
duced clustering in muscle cells as well as agrin induced AChR beta-subunit phospho-
rylation. This results are in concordance with the findings of [Zhu et al., 2008]. The
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researchers showed that inhibition of MuSK endocytosis, by expressing dynamin-K44A
attenuates agrin-induced AChR clustering in muscle cells. They also showed that MuSK
undergoes rapid endocytosis after agrin stimulation, very much like other receptor ty-
rosine kinases such as EGFR (epidermal growth factor receptor) and ErbB4, which are
known to internalize after ligand stimulation [Vieira et al., 1996, Yang et al., 2005]. All
this findings suggest an important influence of MuSK endocytosis on agrin-induced MuSK
signaling.
The partition of MuSK into lipid rafts increases after agrin stimulation, and this translo-
cation depends on its tyrosine kinase activity [Zhu et al., 2006]. The dynamic behavior of
MuSK into lipid rafts is most analogous to other RTKs, including TrkB [Suzuki et al., 2004],
c-Ret [Paratcha & Iba´n˜ez, 2002], and ErbB4 [Ma et al., 2003]. Once stimulated by the
respective ligand, these transmembrane kinases translocate into lipid rafts, and such
translocation is necessary for signaling. Remarkably, MuSK translocation to rafts is fol-
lowed by the recruitment of the AChR, suggesting a sequential signal transduction within
lipid rafts. Importantly, lipid raft disruption, either by removing cholesterol from the
membrane or by reducing the glycosphingolipid level, inhibits MuSK signaling, includ-
ing MuSK phosphorylation, AChR beta-subunit phosphorylation, and activation of the
Rac1 GTPases [Zhu et al., 2006]. Therefor it appears possible that a ligand-dependent
turnover of MuSK via lipid rafts takes place and this turnover could be important for the
recruitment and stability of AChR clusters.
Upon agrin engagement, actin and actin-nucleation factors such as Arp2/3 and N-WASP
were transiently recovered within raft fractions suggesting that the activation by agrin
can trigger actin polymerization [Pato et al., 2008]. Therefor, the present data suggest
that AChR clustering at the neuromuscular junction relies upon a mechanism of raft
coalescence driven by agrin-elicited actin polymerization. Dynamin may regulate actin
filaments coordinately with its activities that remodel membranes [Schafer, 2004]. So,
dynasore might also lead to a reduction of the agrin-MuSK signaling in muscle cells, due
to the blockage of dynamin that perturbs actin polymerization and destabilises the entire
mechanism of AChR clustering.
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5.2 Internalization of MuSK in MuSK
−/−
/MuSK-
SBP myotubes
The generation of a muscle cell line expressing a SBP-tagged MuSK, enables the visuali-
sation of MuSK receptor and its internalization at the NMS. AChR is present in nonraft
microdomains in naive muscle cells and the cluster formation is detectable by 4 h and is
maximal after 8 h of agrin stimulation in lipid rafts. I could show that, after 8 hours of
agrin stimulation, MuSK colocalises with AChR clusters at the level of lipid raft platform
marked with CT. This finding is consistent with other discoveries [Zhu et al., 2006] show-
ing that agrin-induced AChR clusters colocalise with lipid rafts in muscle cells. We are
interested in the visualisation of MuSK distribution upon agrin-stimulation. In my study
I was able to show a partial colocalisations of MuSK with EEA1 (early endosome antigen
1) positive early endosomes after a 10min stimulation with agrin. EEA1 early endosomes
are found in clathrin-dependent internalization as well as in lipid raft internalization
pathways.
Endocytosis of cell surface receptors is an important regulatory event in signal transduc-
tion. For example, TGF-beta receptors internalize into both caveolin- and EEA1-positive
vesicles and reside in both lipid raft and non-raft membrane domains. Clathrin-dependent
internalization into the EEA1-positive endosome, where the Smad2 anchor SARA is en-
riched, promotes TGF-beta signaling. In contrast, the lipid raft-caveolar internalization
pathway contains the Smad7-Smurf2 bound receptor and is required for rapid receptor
turnover. Thus, segregation of TGF-beta receptors into distinct endocytic compartments
regulates either Smad activation or receptor turnover [Di Guglielmo et al., 2003].
Another example where endocytosis plays an important role in signaling is represented by
ErbB tyrosine kinases which become rapidly internalized in response to its ligand neureg-
ulin. The internalization requires the kinase activity of ErbB and involves a clathrin-
dependent endocytic pathway. Moreover, neuregulin-induced Erk activation and AChR
expression were attenuated when ErbB endocytosis was blocked. These results indicate
that ErbB proteins undergo endocytosis in response to neuregulin, and this process is
required for neuregulin signaling and induced AChR expression [Yang et al., 2005].
Taken together, accumulating evidence suggests a tight cross-talk between signaling and
endocytosis. Thus it will be of great importance to study MuSK endocytosis in more
detail to elucidate its influence on MuSK signaling.
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5.3 Outlook
In future experiments, MuSK endocytosis will be further characterized. There are various
methods to detect if a receptor is internalised via a clathrin-dependent or -independent
endocytosis. For example, we can block clathrin-independent endocytic pathways using
β-methylcyclodextrin or nystatin that leads to cholesterol depletion. As control for this
experiment we can perform a sucrose density gradient centrifugation or staining with CT
that should not bind anymore if lipid rafts are depleted. We could express dominant-
negative mutants of caveolin, flotillin, Rho A and other proteins involved in different
endocytic pathways. Alternatively, these proteins can be down-regulated using siRNA.
These experiments should be performed in HeLa cells as well as in other type of cells that
are richer in lipid rafts, for example in fibroblasts.
On the other hand, the clathrin dependent endocytosis can be disturbed by interfering
with several accessory proteins that are implicated in the formation of clathrin-coated
vesicles, as indicated by their ability to interact with other endocytic components like
clathrin and AP-2 (adaptor protein 2) [Mousavi et al., 2004]. Expression of fragments of
these proteins that contain functional domains, inhibit clathrin-dependent endocytosis.
A mutant AP-2 lacking a functional phosphoinositide binding site acts as a dominant-
negative inhibitor of coated pit formation [Owen et al., 2004]. Exposing live cells to
hypertonic sucrose can also inhibit clathrin-mediated endocytosis [Heuser, 1989].
Other future plans will concentrate on the muscle cell line expressing the SBP tagged
MuSK. MuSK internalization will be followed and the possible colocalisation with dif-
ferent endocytic compartments will be studied. We can specifically stain early and late
endosomes, as well as lysosomes and Golgi apparatus. We can also use tagged pro-
teins, like flotillin-GFP or caveolin-GFP and see if there are colocalisations with MuSK.
Another future plan is to see the influence of ubiquitin on the endocytosis pathways
[Sigismund et al., 2005].
A very important future plan is to study MuSK distribution at the NMS compared with
AChR clusters in the presence or absence of agrin. This could lead to a better under-
standing of MuSK localisation and function during NMS assembly and disassembly and
could answer the question whether MuSK is internalised before reaching the lipid rafts,
or the translocation occurs due to a horizontal movement within the plasma membrane.
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Chapter 6
Materials and methods
6.1 Chemical Reagents
10xPBS Gibco
40% Acrylamide Roth
Acetic acid Roth
Agar-Agar Roth
Alexa 488 Conjugated Streptavidin Invitrogen
Alexa 594 Conjugated Streptavidin Invitrogen
Ampicillin Roth
APS Roth
BSA Roth
Bromphenolblue Roth
Calcium chloride Roth
Cholera Toxin B Subunit from Vibrio cholerae FITC Conjugate Sigma-Aldrich
Cy3 Conjugated Streptavidin Jackson ImmunoResearch
Cy3 Conjugated AffiniPure Donkey Anti-Mouse IgG Jackson ImmunoResearch
Cy5 Conjugated Streptavidin Jackson ImmunoResearch
Dynasore monohydrate Sigma-Aldrich
DMEM Sigma
DMSO Roth
EDTA Promega
Ethanol Roth
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Ethidium bromide Roth
FBS Sigma
Gelatin Sigma
Glycerol Roth
Glycine Promega
HCl Roth
Iodoacetamide Sigma
Isopropanol Roth
Kanamycin Roth
LB-broth Roth
Lumi Light Roche
Methanol Roth
MgCl2 Roth
MgSO4 Roth
Midi prep kit Invitrogen
Mini prep kit Fermentas
Modifying enzymes Fermentas
NaOH Roth
NP-40 Sigma
OptiMem Gibco
Paraformaldehyde FLUKA
Penicillin/Streptomycin Sigma
Phenol/Chloroform Roth
PEG Roth
Potassium chloride Roth
Prestained protein ladder Fermentas
Protein A-agarose Roche
Purified Mouse Anti-EEA1 BD Transduction Laboratories
Restriction enzymes Fermentas
Rhodamine Conjugated Human Transferrin Rockland
Silicone glass wool Bertoni
Sodium acetate Roth
Sodium chloride Roth
Sodium dodecyl sulfate SERVA
Sodiumdihydrogen phosphate Roth
Sodiumfluoride (NaF) Fluka Chemika
Sodiumhydrogen phosphate Roth
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Streptavidin Agarose Novagen
streptavidin and Fluorescent Conjugates of Streptavidin Invitrogen
Texas-red-α-bungarotoxin Molecular Probes
Tris Roth
Triton X-100 Sigma
Trypsin-EDTA Gibco
Tween 20 Promega
Vectashield VECTOR
α-MuSK antibody R. Herbst ([Herbst & Burden, 2000])
α-phosphotyrosine antibody (Cell Signaling p100; Santa Cruz p99)
α-bungarotoxin, Alexa Fluor 594 conjugate Molecular Probes
β-Mercaptoethanol Roth
6.2 Plasmids
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6.3 Plasmid preparation
6.3.1 Small scale plasmid preparation
1.5-3 ml of an overnight culture (in LB medium containing 50µg/ml Ampicillin or 30µg/ml
Kanamycin) were centrifuged at maximum speed in an Eppendorf 5415 D centrifuge and
plasmids were isolated using the Fermentas GeneJetTM Plasmid Miniprep kit. All steps
were carried out as recommended by the manufacturer.
6.3.2 Large scale plasmid preparation
150ml of an overnight culture (in LB medium containing 50µg/ml Ampicillin or 30µg/ml
Kanamycin) were centrifuged at 3500rpm in an Eppendorf 5804 centrifuge using the A-
4-44 swinging-bucket rotor. Plasmids were isolated using the Invitrogen Pure LinkTM
HiPure Plasmid Filter Purification Kits Midiprep kit. All steps were carried out as
recommended by Invitrogen. The DNA concentration was determined by measuring an
aqueous dilution at 260nm.
6.4 Manipulation of DNA with enzymes
6.4.1 Restriction enzyme digestion
Enzymes were supplied by Fermentas or New England Biolabs and used as suggested
by the manufacturer. Digestions were mostly carried out in a 20µl volume using 0.5-1µl
restriction enzyme solution and approximately 0.5 to 1µg of DNA.
6.4.2 Ligation of DNA
Ligation reactions were always carried out in a 20µl volume with a molar ratio of vector
to insert of approximately 1:3, except for very small inserts, which were used in higher
excess. Prior to ligation, vector and insert were digested with restriction enzymes that
produced the same or compatible cohesive ends. The ligation was performed by combining
vector and insert DNA in an Eppendorf tube and adding 1µl T4 DNA ligase (5u/µl), 2µl
10x T4 buffer and dH2O up to 20µl. After an incubation of 2h at RT, the whole ligation
mix was transformed into competent bacteria.
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6.4.3 Dephosphorylation of DNA
For dephosphorylation of linearized plasmids 1 µl of SAP (shrimp alkaline phosphatase,
1u/µl) was added right after digestion, followed by a 1h incubation period at 37◦C.
6.5 Isolation of DNA restriction fragments
Digested DNA was run on a 0.7-2% agarose gel/1xTAE containing 2µl EtBr per 50ml
of gel. The bands were visualized by UV. DNA containing agarose blocks were cut
out and centrifuged against a plug of siliconized glass wool. Then a phenol/chloroform
extraction was carried out by adding 1 volume phenol/chloroform, centrifugation for 5min
at maximum speed in a table-top centrifuge and removal of the upper phase. Finally, the
DNA was precipitated with 3 volumes of ethanol/0.3M sodium acetate and washed with
70% ethanol. The pellet was dissolved in TE and stored at -20◦C or used immediately
for ligation. Concentrations of isolated DNA fragments were estimated by loading 1µl
aliquots onto an agarose gel and comparing the resulting bands to the marker, that was
loaded at known concentration.
6.6 Transformation of competent bacteria
In an Eppendorf reaction tube 20 µl ligation mix, 20 µl 5xKCM buffer, 60 µl dH2O and
100 µl competent bacteria were mixed. Then the tube was placed on ice for 30min, after-
wards on 42◦C for a 2min heat shock and then put back on ice again. After the addition
of 900 l LB medium without antibiotics the tube was incubated at 37◦C in a water bath
for 30min. Then the cells were pelleted and 1ml of the supernatant was discarded. The
pellet was resuspended and plated on selection media.
5x KCM buffer: 0.5M KCl
0.15M CaCl2
0.25M MgCl2
6.7 Protein gel electrophoresis and western blot anal-
ysis
Different percentage polyacrylamid gels were prepared, according to the size of proteins
to be analyzed. Samples were loaded into the gel slots and gels were run at 140-180V in
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1xRunning Buffer. After separation of the proteins, the gels were removed from the elec-
trophoresis apparatus and immediately put into transfer buffer. For Western blot analysis
the gel was placed on top of a PVDF-membrane (which was incubated in methanol and
washed with transfer buffer right before) between two transfer buffer-drained papers in a
blotting apparatus and a current of 50mA was applied per gel. The proteins were allowed
to transfer to the membrane for 1h. Afterwards, the membrane was immediately put into
TBS-Tween for washing. For further analysis the membrane has to be blocked. This was
achieved by incubating the membrane for 2h on a shaker at room temperature in a 5%
BSA/TBS-Tween solution. The primary antibody in 5% BSA + 0.1% NaN3 in TBS-
Tween, was added to the membrane. After 1h at RT or overnight incubation at 4◦Cthe
membrane was washed 3 times with TBS-Tween and then the secondary horse reddish
peroxidase conjugated antibody, diluted in 5% instant milk powder in TBS-Tween, was
added. After 1h, the membrane was washed 3 times and incubated with Roche Lumi-
Light. The bands were visualized by subjecting the membranes to BIO-RAD Fluor-STM
MultiImager. Bands were analyzed using BIO-RAD Quantity One - 4.1.1 Software. To
remove the antibody binding, blots can be stripped in 10% acetic acid for 2h on a shaker
and afterwards washed 3 times with water. Then the blots could be reused for another
antibody reaction.
6.7.1 Solutions and gels
5xRunning Buffer: 15.05g Tris base
72 g glicine
dissolved in almost 1l dH2o
5g SDS were added and the volume adjusted to 1l
Transfer Buffer: 25mM Tris pH 8
192mM glycine
20% methanol
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6.8 Cell culture
6.8.1 HeLa cell line
HeLa cells were grown in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin
(=general medium, GM). The incubator was adjusted to 37◦C and 6% CO2. Cells were
split every second day when they were about 80-90% confluent.
6.8.2 C2C12 cells
C2C12 cells were grown in DMEM supplemented with 15% FBS, 0.25% chicken embry-
onic exctract and 1% penicillin/streptomycin (=general medium, GM). The incubator
was set to 37◦C and 6% CO2. Cells were split every two days when they were about 80-
90% confluent. For differentiation of C2C12 myoblasts into myotubes cells were plated
( 1.3*105 cells / 3.5cm dish) on gelatine coated dishes and switched to DMEM supple-
mented with 2% HS and 1% penicillin/streptomycin (=differentiation medium, DM) at
90% confluency. DM was changed every 24 hrs. for 3 days until myotube formation was
accomplished.
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6.8.3 C3.16 mutant cell line
The C3.16 (MuSK
−/−
) cell growth induced by large T oncogene expression requires
expansion of this cell line at 33◦C and 6% CO2. Cells were grown on gelatine coated dishes
in DMEM supplemented with 10% FBS, 10% HS, 0.25% chicken embryonic exctract,
200µl IFN-γ / 100ml GM and 1% penicillin/streptomycin (=general medium, GM). For
differentiation of C3.16 myoblasts into myotubes cells were plated ( 1*106 cells / 10cm
dish) on matrix gel coated dishes. Cells were switched to DMEM supplemented with 10%
FBS, 10% HS and 1% penicillin/streptomycin (=differentiation medium, DM) at 100%
confluency and moved to 37◦C and 6% CO2. DM was changed every 24 hrs. for 3 days
until myotube formation was accomplished. In the case of C3.16/MuSK-SBP cell lines,
GM was supplemented with puromycin 10µl / 100ml GM.
6.8.4 Freeze cells
A 10cm plate of happily growing cells that were about 60-70% confluent was trypsinized.
The cells were washed off the plate with 5ml GM, then centrifuged for 5min at 1500rpm.
The cell pellet was well resuspended in 1ml freeze medium (GM + 10% DMSO). Cells
were frozen at -80◦C and subsequently put into a liquid nitrogen for longtime storage.
6.9 Transfection of HeLa cells by Ca2+ DNA pre-
cipitation
HeLa cells were cultured on glass coverslips (20mm diameter) and the coverslips were
placed in a 6-well dish. 2x BBS and the 0.25M CaCl2 solutions were thawed quickly and
placed at room temperature. For every 3.5 cm plate from the 6-well dish, 4-5 µg DNA
were used and pipetted into a round bottom polystyrene tube. Then, 175 µl 0.25M CaCl2
were added and the solution was vortexed. Afterwards, 175 µl 2xBBS were added and
the tube was vortexed again, followed by incubation at room temperature for 13-15min.
After this incubation step, the DNA mix was added drop-wise on top of the cells. 12-15h
after transfection, the growth medium was changed to remove the precipitate and let
the cells recover In case of cotransfection, 3 µg DNA of MuSK-SBP and 2 µg DNA of
dynamin plasmid were used for every 3.5 cm dish.
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2XBBS: 80ml sterile ddH2O
5.6ml 5M NaCl
5.0ml 1M BES
150µl 1M Na2HPO4
pH adjusted to 6.95
volume raised to 100ml
6.10 Lysates of HeLa / C2C12/ C3.16 cells
Cells ready for processing were put on ice and the growth medium was aspirated. The
cells were washed twice with ice-cold PBS. Afterwards, RIPA lysis buffer containing pro-
tease inhibitors was added (1ml per 10cm plate, 500µl per 6 cm plate). For lysis to occur,
plates were left on a shaker at 4◦C for 30min. Then the cells were scraped off each plate
and transferred into an Eppendorf tube. Lysates were centrifuged at 4◦C for 10min at
maximum speed in an Eppendorf 5415 D centrifuge. The supernatants were transferred
into new centrifuge tubes. Samples were either used immediately for further analysis or
frozen in liquid nitrogen and stored at -80◦C. Protease inhibitors Leupeptin, Pepstatin,
Orthovanadate phosphatase, Aprotinin and PMSF were added to the lysis buffer right
before usage.
RIPA Buffer: 50 mM Tris-HCl, pH 7,5
150 mM NaCl
1% NP-40
0,5% DOC
50 mM NaF
dissolved in almost 200ml dH2o
volume adjusted to 200ml
6.11 Immunoprecipitation
Cell lysate aliquots of 500 µl were incubated with the respective antibody at 4◦C on a
rotating device. After 15 hrs. incubation 20 µl protein A agarose beads was added and
incubated for 1 hr. on a rotating device at 4◦C. Lysates were centrifuged for 1 min at
maximum speed in an Eppendorf 5415 D centrifuge. The protein A agarose beads were
washed 3 times using 1 ml of ice cold Ripa lysis buffer containing protease inhibitors.
Bound proteins were eluted with SDS sample buffer, incubated for 5min at 95◦C and
subjected to SDS-PAGE.
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6.12 Pull down experiments
To isolate AChRs, muscle cell lysate aliquots of 500 µl were thawed from -80◦C on ice and
incubated with biotin-conjugated α-BTX for 1 hr at 4◦C. Afterwards, 20 µl streptavidin-
coupled agarose beads were added and samples were incubated for 1 hr at 4◦C on a
rotating device. Lysates were centrifuged for 1.5 min at maximum speed in an Eppendorf
5415 D centrifuge. Streptavidin-coupled agarose beads were washed 3 times using 1 ml
RIPA lysis buffer containing protease inhibitors. Bound proteins were eluted with SDS
sample buffer and subjected to SDS-PAGE.
6.13 Immunofluorescence microscopy
Transiently transfected HeLa cells, cultured on glass coverslips (20mm diameter) were
washed three times with cold PBS and surface MuSK-SBP receptors were stained for
30min at 4◦C with SA-Cy3 or SA-Alexa 594. After staining, cells were washed 3X with
cold PBS to remove the free fluorophore and incubated for different time intervals at 37◦C
in DMEM to let endocytosis to occur. Afterwards cells were washed again in cold PBS
and stained for 30min at 4◦C with SA-Cy5 or SA-Alexa 488. Cells were washed and fixed
with 4% PFA in PBS for 10min at RT. After fixation, PBS washing was repeated and
coverslips were mounted onto glass slides in Vectashield mounting medium, sealed with
nail polish and viewed on a fluorescence microscope using different excitation wavelengths.
Muscle cells were cultivated on 3.5 cm dishes. Plates were washed at room temperature
with PBS and fixed with 4% PFA in PBS for 10min at RT. After fixation, PBS washing
was repeated and cells were stained with Alexa-594 conjugated α-Bungarotoxin for 60
min for 60min. Cells were washed in PBS to remove the unbound fluorophor and fixed
with 4% PFA in PBS for 10min at RT. After another three washing steps with PBS, cov-
erslips and Vectashield mounting medium were used to stabilize the sampels. Coverslips
were sealed with nail polish and sampels were visualised with a fluorescent microscope.
In order to specifically label endocytic compartments as the EEA1 early endosomes in
muscle cells, C3.16/MuSK-SBP myotubes were first fixed with 4% PFA in PBS for 15min
at RT. After fixation, cells were washed in PBS and treated with 0.1mM glycine in PBS for
10min. For permeabilization, cells were incubated with 0.2% Triton in PBS for 10min at
RT. Cells were washed 2 times in PBS and then blocked in blocking solution (10% FBS in
PBS) for 30min at RT. Then, the cells were incubated with anti-EEA1 antibody diluted
with blocking solution for 1 hours at RT. Afterwards, cells were washed three times
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with PBS, blocked for 20 min in blocking solution and incubated with species-specific
secondary fluorophore-conjugated antibodies diluted in blocking solution for 1 hour at
RT. Cells were washed in PBS for 5 minutes on a shaker and mounted in Vectashield
mounting medium. Sampels were visualized with a fluorescence microscope.
6.14 Quantification of AChR clusters
Quantification of the AChR cluster length and number was done using the Metamorph
Imaging Software (Molecular Devices). At least 10 pictures of AChR clusters on the
surface of myotubes were taken, from random chosen fields, using the 63x objective. The
AChR cluster length was determined by applying a line across the cluster using the free
hand tool of the software. The length as well the number of all marked AChR clusters was
automatically calculated using ”‘region measurements”’ function of the software. Clusters
smaller then 2 µm were excluded from the statistical analysis. Data was imported and
processed with Microsoft Excel Software.
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6.15 Solutions and buffers
10xTBS-Tween: 100mM Tris.Cl pH8
1.5M NaCl
0.5 % Tween 20
10xPBS: 1.37M NaCl
27mM KCl
43mM Na2HPO4
14mM KH2PO4
4xSDS Loading Buffer: 240mM Tris.Cl pH6.8
8% -Mercaptoethanol
8% SDS
40% glycerol, bromphenol blue
50xTAE: 242g Tris base
57.1ml acetic acid
100ml 0.5M EDTA
volume adjusted to 1l with dH2O
4% PFA: 0.8g PFA were dissolved in 20ml 1xPBS
100 µl 0.5M NaOH to reach pH7
The solution was gently heated and stirred until clear
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Chapter 7
Abbreviations
APS ammoniumperoxidisulfate
ATP adenosine triphosphate
bp base pair
BLAST basic local alignment research tool
BBS BES buffered saline
BES N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid
BLAST basic local alignment research tool
BSA bovine serum albumin
Da Dalton
DMEM Dulbeco’s Modified Eagles Medium
DMSO dimethylsulfoxide
dNTPs deoxyribonucleoside triphosphates
EDTA ethylenediaminetetraacetate
EtBr ethidium bromide
FBS fetal bovine serum
GEF guanine nucleotide exchange factor
GFP green fluorescent protein
hr hour
HEPES 2-[4-(2-Hydroxyethyl)-1-piperazinyl]-ethanesulphonic acid
kb kilobase
67
kDa kiloDalton
min minute
NP-40 Nonidet P-40
nt nucleotide
oligo oligonucleotide
PAGE polyacrylamide gel electrophoresis
PBS phosphate-buffered saline
PFA paraformaldehyde
PMSF phenylmethylsulfonylfluoride
pTyr phosphotyrosine
RT room temperature
SDS sodium dodecyl sulfate
sec second
TAE tris-acetate-EDTA
TBS tris-buffered saline
TBE tris-borate-EDTA
TE tris-EDTA
TEA triethanolamine acetate
TEMED N,N,N,N-tetramethylethylene diamine
Tris tris (hydroxymethyl) aminomethane
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